These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
716 related articles for article (PubMed ID: 32003672)
21. Cerebral inoculation of human A53T α-synuclein reduces spatial memory decline and amyloid-β aggregation in APP/PS1 transgenic mice of Alzheimer's disease. Hao YN; Lu QX; Zhai YH; Wang HY; Wu MN; Hu MM; Yang B; Wang ZJ; Wu ZW; Qi JS Brain Res Bull; 2018 Oct; 143():116-122. PubMed ID: 30366065 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-574 is involved in cognitive impairment in 5-month-old APP/PS1 mice through regulation of neuritin. Li F; Wei G; Bai Y; Li Y; Huang F; Lin J; Hou Q; Deng R; Zhou JH; Zhang SX; Chen DF Brain Res; 2015 Nov; 1627():177-88. PubMed ID: 26423933 [TBL] [Abstract][Full Text] [Related]
23. miR-3940-5p reduces amyloid β production via selectively targeting Qi Y; Wang X; Guo X Front Aging Neurosci; 2024; 16():1346978. PubMed ID: 38501059 [TBL] [Abstract][Full Text] [Related]
24. MicroRNA-326 decreases tau phosphorylation and neuron apoptosis through inhibition of the JNK signaling pathway by targeting VAV1 in Alzheimer's disease. He B; Chen W; Zeng J; Tong W; Zheng P J Cell Physiol; 2020 Jan; 235(1):480-493. PubMed ID: 31385301 [TBL] [Abstract][Full Text] [Related]
25. LncRNA Rpph1 protects amyloid-β induced neuronal injury in SK-N-SH cells via miR-122/Wnt1 axis. Gu R; Wang L; Tang M; Li SR; Liu R; Hu X Int J Neurosci; 2020 May; 130(5):443-453. PubMed ID: 31718352 [No Abstract] [Full Text] [Related]
26. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice. Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230 [TBL] [Abstract][Full Text] [Related]
27. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition. Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688 [TBL] [Abstract][Full Text] [Related]
28. MiR-191-5p alleviates microglial cell injury by targeting Map3k12 (mitogen-activated protein kinase kinase kinase 12) to inhibit the MAPK (mitogen-activated protein kinase) signaling pathway in Alzheimer's disease. Wan W; Liu G; Li X; Liu Y; Wang Y; Pan H; Hu J Bioengineered; 2021 Dec; 12(2):12678-12690. PubMed ID: 34818971 [TBL] [Abstract][Full Text] [Related]
29. miR-15b reduces amyloid-β accumulation in SH-SY5Y cell line through targetting NF-κB signaling and BACE1. Li J; Wang H Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 29961672 [TBL] [Abstract][Full Text] [Related]
31. CART mitigates oxidative stress and DNA damage in memory deficits of APP/PS1 mice via upregulating β‑amyloid metabolism‑associated enzymes. Jiang H; Niu F; Zheng Y; Xu Y Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33604684 [TBL] [Abstract][Full Text] [Related]
32. MicroRNA-20b-5p aggravates neuronal apoptosis induced by β-Amyloid via down-regulation of Ras homolog family member C in Alzheimer's disease. Tian Z; Dong Q; Wu T; Guo J Neurosci Lett; 2021 Jan; 742():135542. PubMed ID: 33278507 [TBL] [Abstract][Full Text] [Related]
33. miR-34a deficiency in APP/PS1 mice promotes cognitive function by increasing synaptic plasticity via AMPA and NMDA receptors. Xu Y; Chen P; Wang X; Yao J; Zhuang S Neurosci Lett; 2018 Mar; 670():94-104. PubMed ID: 29378298 [TBL] [Abstract][Full Text] [Related]
34. Protective mechanism of gold nanoparticles on human neural stem cells injured by β-amyloid protein through miR-21-5p/SOCS6 pathway. Wang G; Shen X; Song X; Wang N; Wo X; Gao Y Neurotoxicology; 2023 Mar; 95():12-22. PubMed ID: 36623431 [TBL] [Abstract][Full Text] [Related]
35. Circulating Small Extracellular Vesicle-Derived miR-342-5p Ameliorates Beta-Amyloid Formation via Targeting Beta-site APP Cleaving Enzyme 1 in Alzheimer's Disease. Dong Z; Gu H; Guo Q; Liu X; Li F; Liu H; Sun L; Ma H; Zhao K Cells; 2022 Nov; 11(23):. PubMed ID: 36497090 [TBL] [Abstract][Full Text] [Related]
36. miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer's disease. Sun T; Zhao K; Liu M; Cai Z; Zeng L; Zhang J; Li Z; Liu R Pharmacol Res; 2022 Apr; 178():106153. PubMed ID: 35257899 [TBL] [Abstract][Full Text] [Related]
37. SLOH, a carbazole-based fluorophore, mitigates neuropathology and behavioral impairment in the triple-transgenic mouse model of Alzheimer's disease. Wu X; Kosaraju J; Zhou W; Tam KY Neuropharmacology; 2018 Mar; 131():351-363. PubMed ID: 29309769 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of miR-96-5p May Reduce Aβ42/Aβ40 Ratio via Regulating ATP-binding cassette transporter A1. Zhu M; Jia L; Jia J J Alzheimers Dis; 2021; 83(1):367-377. PubMed ID: 34334400 [TBL] [Abstract][Full Text] [Related]
39. MicroRNA-455-5p/CPEB1 pathway mediates Aβ-related learning and memory deficits in a mouse model of Alzheimer's disease. Xiao G; Chen Q; Zhang X Brain Res Bull; 2021 Dec; 177():282-294. PubMed ID: 34678444 [TBL] [Abstract][Full Text] [Related]
40. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model. Chum PP; Hakim MA; Behringer EJ J Alzheimers Dis; 2022; 85(1):91-113. PubMed ID: 34776451 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]